{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:32Z","timestamp":1794898892331,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>So far the pathomechanism of preeclampsia in pregnancy is focussed on increased circulating levels of soluble fms-like tyrosin kinase-1 (sFLT-1) that neutralizes glomerular VEGF-A expression and prevents its signaling at the glomerular endothelium. As a result of changed glomerular VEGF-A levels endotheliosis and podocyte foot process effacement are typical morphological features of preeclampsia. Recently, microRNA-26a-5p (miR-26a-5p) was described to be also upregulated in the preeclamptic placenta. We found that miR-26a-5p targets VEGF-A expression by means of PIK3C2\u03b1 in cultured human podocytes and that miR-26a-5p overexpression in zebrafish causes proteinuria, edema, glomerular endotheliosis and podocyte foot process effacement. Interestingly, recombinant zebrafish Vegf-Aa protein could rescue glomerular changes induced by miR-26a-5p. In a small pilot study, preeclamptic patients with podocyte damage identified by podocyturia, expressed significantly more urinary miR-26a-5p compared to healthy controls. Thus, functional and ultrastructural glomerular changes after miR-26a-5p overexpression can resemble the findings seen in preeclampsia and indicate a potential pathophysiological role of miR-26a-5p in addition to sFLT-1 in this disease.<\/jats:p>","DOI":"10.1038\/s41598-018-22070-w","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:35:56Z","timestamp":1519144556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish"],"prefix":"10.1038","volume":"8","author":[{"given":"Janina","family":"M\u00fcller-Deile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Beverly-Staggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"22070_CR1","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1681\/ASN.2007020255","volume":"18","author":"IE Stillman","year":"2007","unstructured":"Stillman, I. E. & Karumanchi, S. A. The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 18, 2281\u20132284 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"22070_CR2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","volume":"50","author":"A Hertig","year":"2004","unstructured":"Hertig, A. et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin. Chem. 50, 1702\u20131703 (2004).","journal-title":"Clin. Chem."},{"key":"22070_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5527\/wjn.v3.i4.169","volume":"3","author":"J Muller-Deile","year":"2014","unstructured":"Muller-Deile, J. & Schiffer, M. Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy. World J. Nephrol. 3, 169\u2013181 (2014).","journal-title":"World J. Nephrol."},{"key":"22070_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler, H. et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N. Engl. J. Med. 374, 13\u201322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"22070_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672\u2013683 (2004).","journal-title":"N. Engl. J. Med."},{"key":"22070_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","volume":"124","author":"R Thadhani","year":"2011","unstructured":"Thadhani, R. et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940\u2013950 (2011).","journal-title":"Circulation"},{"key":"22070_CR7","doi-asserted-by":"publisher","first-page":"p32","DOI":"10.1159\/000101798","volume":"106","author":"V Eremina","year":"2007","unstructured":"Eremina, V., Baelde, H. J. & Quaggin, S. E. Role of the VEGF\u2013a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol. 106, p32\u20137 (2007).","journal-title":"Nephron Physiol."},{"key":"22070_CR8","doi-asserted-by":"publisher","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","volume":"297","author":"J Muller-Deile","year":"2009","unstructured":"Muller-Deile, J. et al. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am. J. Physiol. Renal Physiol. 297, F1656\u201367 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"22070_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1042\/CS20150403","volume":"129","author":"L Gnudi","year":"2015","unstructured":"Gnudi, L., Benedetti, S., Woolf, A. S. & Long, D. A. Vascular growth factors play critical roles in kidney glomeruli. Clin. Sci. (Lond) 129, 1225\u20131236 (2015).","journal-title":"Clin. Sci. (Lond)"},{"key":"22070_CR10","doi-asserted-by":"crossref","unstructured":"M\u00fcller-Deile, J., Brocker, V. & Grunwald, V.,. Renal side effects of VEGF-blocking therapy. NDT Plus 2010;3:172-175. NDT Plus 172\u2013175 (2010).","DOI":"10.1093\/ndtplus\/sfp175"},{"key":"22070_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2014.221","volume":"86","author":"TL Weissgerber","year":"2014","unstructured":"Weissgerber, T. L., Craici, I. M., Wagner, S. J., Grande, J. P. & Garovic, V. D. Advances in the pathophysiology of preeclampsia and related podocyte injury. Kidney Int. 86, 445 (2014).","journal-title":"Kidney Int."},{"key":"22070_CR12","doi-asserted-by":"publisher","first-page":"176973","DOI":"10.1155\/2011\/176973","volume":"2011","author":"J Muller-Deile","year":"2011","unstructured":"Muller-Deile, J. & Schiffer, M. Renal involvement in preeclampsia: similarities to VEGF ablation therapy. J. Pregnancy 2011, 176973 (2011).","journal-title":"J. Pregnancy"},{"key":"22070_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707\u2013716 (2003).","journal-title":"J. Clin. Invest."},{"key":"22070_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F. & Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231\u2013235 (2004).","journal-title":"Nature"},{"key":"22070_CR15","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1515\/cclm-2012-0360","volume":"50","author":"Y Sun","year":"2012","unstructured":"Sun, Y., Zhang, K., Fan, G. & Li, J. Identification of circulating microRNAs as biomarkers in cancers: what have we got? Clin. Chem. Lab. Med. 50, 2121\u20132126 (2012).","journal-title":"Clin. Chem. Lab. Med."},{"key":"22070_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3892\/br.2015.524","volume":"3","author":"Q Li","year":"2015","unstructured":"Li, Q. et al. Quantification of preeclampsia-related microRNAs in maternal serum. Biomed. Rep. 3, 792\u2013796 (2015).","journal-title":"Biomed. Rep."},{"key":"22070_CR17","doi-asserted-by":"publisher","first-page":"661.e1","DOI":"10.1016\/j.ajog.2008.12.045","volume":"200","author":"XM Zhu","year":"2009","unstructured":"Zhu, X. M., Han, T., Sargent, I. L., Yin, G. W. & Yao, Y. Q. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am. J. Obstet. Gynecol. 200, 661.e1\u2013661.e7 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"22070_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3892\/br.2016.779","volume":"5","author":"C Munaut","year":"2016","unstructured":"Munaut, C. et al. Dysregulated circulating miRNAs in preeclampsia. Biomed. Rep. 5, 686\u2013692 (2016).","journal-title":"Biomed. Rep."},{"key":"22070_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.placenta.2013.06.006","volume":"34","author":"SY Choi","year":"2013","unstructured":"Choi, S. Y. et al. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34, 799\u2013804 (2013).","journal-title":"Placenta"},{"key":"22070_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/REP-11-0304","volume":"143","author":"L Wu","year":"2012","unstructured":"Wu, L. et al. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143, 389\u2013397 (2012).","journal-title":"Reproduction"},{"key":"22070_CR21","doi-asserted-by":"publisher","first-page":"e77957","DOI":"10.1371\/journal.pone.0077957","volume":"8","author":"ZT Chai","year":"2013","unstructured":"Chai, Z. T. et al. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2alpha\/Akt\/HIF-1alpha pathway in hepatocellular carcinoma. PLoS One 8, e77957 (2013).","journal-title":"PLoS One"},{"key":"22070_CR22","doi-asserted-by":"publisher","first-page":"56-015","DOI":"10.1186\/s13045-015-0150-4","volume":"8","author":"ZT Chai","year":"2015","unstructured":"Chai, Z. T. et al. microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K\/Akt pathway in hepatocellular carcinoma. J. Hematol. Oncol. 8, 56-015\u20130150-4 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"22070_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lfs.2015.06.025","volume":"136","author":"W Wang","year":"2015","unstructured":"Wang, W., Zhang, E. & Lin, C. MicroRNAs in tumor angiogenesis. Life Sci. 136, 28\u201335 (2015).","journal-title":"Life Sci."},{"key":"22070_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbaexp.2003.10.006","volume":"1676","author":"B Gong","year":"2004","unstructured":"Gong, B., Liang, D., Chew, T. G. & Ge, R. Characterization of the zebrafish vascular endothelial growth factor A gene: comparison with vegf-A genes in mammals and Fugu. Biochim. Biophys. Acta 1676, 33\u201340 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"22070_CR25","doi-asserted-by":"publisher","first-page":"658270","DOI":"10.1155\/2013\/658270","volume":"2013","author":"N Hanke","year":"2013","unstructured":"Hanke, N. et al. \"Zebrafishing\" for novel genes relevant to the glomerular filtration barrier. Biomed. Res. Int. 2013, 658270 (2013).","journal-title":"Biomed. Res. Int."},{"key":"22070_CR26","doi-asserted-by":"crossref","unstructured":"Hanke, N., King, B. L., Vaske, B., Haller, H. & Schiffer, M. A Fluorescence-Based Assay for Proteinuria Screening in Larval Zebrafish (Danio rerio). Zebrafish (2015).","DOI":"10.1089\/zeb.2015.1093"},{"key":"22070_CR27","first-page":"76-213X","volume":"10","author":"J Xie","year":"2010","unstructured":"Xie, J., Farage, E., Sugimoto, M. & Anand-Apte, B. A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev. Biol. 10, 76-213X\u201310-76 (2010).","journal-title":"BMC Dev. Biol."},{"key":"22070_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253\u2013310 (1995).","journal-title":"Dev. Dyn."},{"key":"22070_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0962-8924(03)00124-7","volume":"13","author":"I Drummond","year":"2003","unstructured":"Drummond, I. Making a zebrafish kidney: a tale of two tubes. Trends Cell Biol. 13, 357\u2013365 (2003).","journal-title":"Trends Cell Biol."},{"key":"22070_CR30","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1093\/ndt\/gfn235","volume":"23","author":"J Achenbach","year":"2008","unstructured":"Achenbach, J. et al. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol. Dial. Transplant. 23, 3138\u20133145 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"22070_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.5301\/jn.5000068","volume":"25","author":"J Mueller-Deile","year":"2012","unstructured":"Mueller-Deile, J. et al. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS. J. Nephrol. 25, 802\u2013809 (2012).","journal-title":"J. Nephrol."},{"key":"22070_CR32","doi-asserted-by":"publisher","first-page":"320.e1","DOI":"10.1016\/j.ajog.2007.02.007","volume":"196","author":"VD Garovic","year":"2007","unstructured":"Garovic, V. D. et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 196, 320.e1\u2013320.e7 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"22070_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/HYPERTENSIONAHA.113.01115","volume":"61","author":"IM Craici","year":"2013","unstructured":"Craici, I. M. et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61, 1289\u20131296 (2013).","journal-title":"Hypertension"},{"key":"22070_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","volume":"5","author":"BC Young","year":"2010","unstructured":"Young, B. C., Levine, R. J. & Karumanchi, S. A. Pathogenesis of preeclampsia. Annu. Rev. Pathol. 5, 173\u2013192 (2010).","journal-title":"Annu. Rev. Pathol."},{"key":"22070_CR35","unstructured":"Kurtoglu, E. et al. Serum VEGF and PGF may be significant markers in prediction of severity of preeclampsia. J. Matern. Fetal. Neonatal Med. 1\u20136 (2015)."},{"key":"22070_CR36","first-page":"228","volume":"34","author":"T Cirpan","year":"2007","unstructured":"Cirpan, T. et al. Evaluation of VEGF in placental bed biopsies from preeclamptic women by immunohistochemistry. Clin. Exp. Obstet. Gynecol. 34, 228\u2013231 (2007).","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"22070_CR37","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/j.1471-0528.1996.tb09627.x","volume":"103","author":"JC Cooper","year":"1996","unstructured":"Cooper, J. C., Sharkey, A. M., Charnock-Jones, D. S., Palmer, C. R. & Smith, S. K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 103, 1191\u20131196 (1996).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"22070_CR38","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","volume":"160","author":"Y Zhou","year":"2002","unstructured":"Zhou, Y. et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160, 1405\u20131423 (2002).","journal-title":"Am. J. Pathol."},{"key":"22070_CR39","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1210\/jc.2003-030528","volume":"88","author":"V Tsatsaris","year":"2003","unstructured":"Tsatsaris, V. et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J. Clin. Endocrinol. Metab. 88, 5555\u20135563 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"22070_CR40","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1042\/BST20110671","volume":"39","author":"DO Bates","year":"2011","unstructured":"Bates, D. O. An unexpected tail of VEGF and PlGF in pre-eclampsia. Biochem. Soc. Trans. 39, 1576\u20131582 (2011).","journal-title":"Biochem. Soc. Trans."},{"key":"22070_CR41","doi-asserted-by":"publisher","first-page":"e44572","DOI":"10.1371\/journal.pone.0044572","volume":"7","author":"JJ Jung","year":"2012","unstructured":"Jung, J. J. et al. Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1\/sFlt1) requires Arf1, Arf6, and Rab11 GTPases. PLoS One 7, e44572 (2012).","journal-title":"PLoS One"},{"key":"22070_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.placenta.2013.06.006","volume":"34","author":"SY Choi","year":"2013","unstructured":"Choi, S. Y. et al. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34, 799\u2013804 (2013).","journal-title":"Placenta"},{"key":"22070_CR43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/bdra.20782","volume":"91","author":"JF Mouillet","year":"2011","unstructured":"Mouillet, J. F., Chu, T. & Sadovsky, Y. Expression patterns of placental microRNAs. Birth Defects Res. A. Clin. Mol. Teratol. 91, 737\u2013743 (2011).","journal-title":"Birth Defects Res. A. Clin. Mol. Teratol."},{"key":"22070_CR44","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00125-015-3642-4","volume":"58","author":"K Koga","year":"2015","unstructured":"Koga, K. et al. MicroRNA-26a inhibits TGF-beta-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Diabetologia 58, 2169\u20132180 (2015).","journal-title":"Diabetologia"},{"key":"22070_CR45","doi-asserted-by":"publisher","unstructured":"M\u00fcller-Deile, J. et al. Identification of Cell-and Disease-Specific Micro RNAs in Glomerular Pathologies. J Mol Genet Med. 11, 277, https:\/\/doi.org\/10.4172\/1747-0862.1000277 (2017).","DOI":"10.4172\/1747-0862.1000277"},{"key":"22070_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1242\/jcs.041913","volume":"122","author":"R Bhattacharya","year":"2009","unstructured":"Bhattacharya, R. et al. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J. Cell. Sci. 122, 1025\u20131034 (2009).","journal-title":"J. Cell. Sci."},{"key":"22070_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.onc.1209002","volume":"25","author":"PF Cezar-de-Mello","year":"2006","unstructured":"Cezar-de-Mello, P. F., Nascimento-Silva, V., Villela, C. G. & Fierro, I. M. Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Oncogene 25, 122\u2013129 (2006).","journal-title":"Oncogene"},{"key":"22070_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vph.2016.05.006","volume":"83","author":"E Porcu","year":"2016","unstructured":"Porcu, E. et al. Vascular disrupting activity of combretastatin analogues. Vascul Pharmacol. 83, 78\u201389 (2016).","journal-title":"Vascul Pharmacol."},{"key":"22070_CR49","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.RES.86.8.892","volume":"86","author":"M Morales-Ruiz","year":"2000","unstructured":"Morales-Ruiz, M. et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine\/threonine kinase Akt. Circ. Res. 86, 892\u2013896 (2000).","journal-title":"Circ. Res."},{"key":"22070_CR50","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/sj.onc.1201380","volume":"15","author":"S Rousseau","year":"1997","unstructured":"Rousseau, S., Houle, F., Landry, J. & Huot, J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15, 2169\u20132177 (1997).","journal-title":"Oncogene"},{"key":"22070_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/00016348309156236","volume":"62","author":"P Jouppila","year":"1983","unstructured":"Jouppila, P., Jouppila, R. & Koivula, A. Albumin infusion does not alter the intervillous blood flow in severe pre-eclampsia. Acta Obstet. Gynecol. Scand. 62, 345\u2013348 (1983).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"22070_CR52","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","volume":"51","author":"T Podymow","year":"2008","unstructured":"Podymow, T. & August, P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 51, 960\u2013969 (2008).","journal-title":"Hypertension"},{"key":"22070_CR53","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1248\/bpb.34.1785","volume":"34","author":"S Takahashi","year":"2011","unstructured":"Takahashi, S. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biol. Pharm. Bull. 34, 1785\u20131788 (2011).","journal-title":"Biol. Pharm. Bull."},{"key":"22070_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben, A. et al. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549\u2013580 (2004).","journal-title":"Pharmacol. Rev."},{"key":"22070_CR55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/HYPERTENSIONAHA.113.01115","volume":"61","author":"IM Craici","year":"2013","unstructured":"Craici, I. M. et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61, 1289\u20131296 (2013).","journal-title":"Hypertension"},{"key":"22070_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.preghy.2011.09.004","volume":"2","author":"D Ramsuran","year":"2012","unstructured":"Ramsuran, D., Moodley, J., Dauth, T. & Naicker, T. The role of podocytes in the early detection of pre-eclampsia. Pregnancy Hypertens. 2, 43\u201347 (2012).","journal-title":"Pregnancy Hypertens."},{"key":"22070_CR57","doi-asserted-by":"crossref","unstructured":"Mestdagh, P. et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10, R64-2009\u201310-6-r64. Epub 2009 Jun 16 (2009).","DOI":"10.1186\/gb-2009-10-6-r64"},{"key":"22070_CR58","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1261\/rna.2345710","volume":"16","author":"C Suo","year":"2010","unstructured":"Suo, C., Salim, A., Chia, K. S., Pawitan, Y. & Calza, S. Modified least-variant set normalization for miRNA microarray. RNA 16, 2293\u20132303 (2010).","journal-title":"RNA"},{"key":"22070_CR59","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","volume":"61","author":"H Schwarzenbach","year":"2015","unstructured":"Schwarzenbach, H., da Silva, A. M., Calin, G. & Pantel, K. Data Normalization Strategies for MicroRNA Quantification. Clin. Chem. 61, 1333\u20131342 (2015).","journal-title":"Clin. Chem."},{"key":"22070_CR60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/REP-11-0304","volume":"143","author":"L Wu","year":"2012","unstructured":"Wu, L. et al. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143, 389\u2013397 (2012).","journal-title":"Reproduction"},{"key":"22070_CR61","doi-asserted-by":"publisher","first-page":"F1746","DOI":"10.1152\/ajprenal.00009.2007","volume":"293","author":"DM Hentschel","year":"2007","unstructured":"Hentschel, D. M. et al. Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am. J. Physiol. Renal Physiol. 293, F1746\u201350 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22070-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:48:57Z","timestamp":1671590937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22070-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22070-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"4 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3621"}}